Pure Global

The Effectiveness of Virtual Reality on Anxiety Reduction in Women Undergoing Elective Egg Cryopreservation. - Trial NCT06280222

Access comprehensive clinical trial information for NCT06280222 through Pure Global AI's free database. This phase not specified trial is sponsored by Hadassah Medical Organization and is currently Recruiting. The study focuses on Anxiety. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06280222
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06280222
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Effectiveness of Virtual Reality on Anxiety Reduction in Women Undergoing Elective Egg Cryopreservation.
Virtual Reality (VR)-Based Intervention to Improve Pre-operative Anxiety in Patients Undergoing Elective Oocyte Cryopreservation: a Randomized Clinical Trial

Study Focus

Anxiety

The VR instrument - Oculus Quest 2

Interventional

device

Sponsor & Location

Hadassah Medical Organization

Jerusalem, Israel

Timeline & Enrollment

N/A

Nov 15, 2023

Feb 01, 2025

30 participants

Primary Outcome

Vital signs,Vital signs,VAS (visual-analogue scale),State and Trait Anxiety (STAI) Score

Summary

A randomized trial assessing the effectiveness of virtual reality exposure prior to an oocyte
 retrieval procedure in terms of anxiety level .

ICD-10 Classifications

Anxiety disorder, unspecified
Other anxiety disorders
Phobic anxiety disorders
Phobic anxiety disorder, unspecified
Generalized anxiety disorder

Data Source

ClinicalTrials.gov

NCT06280222

Device Trial